In colon cancer and thyroid cancer patients, CTHRC1 expression levels were negatively associated with OS, and univariate COX regression analysis showed that CTHRC1 was an important risk factor correlated with patient OS rates. Here, CTHRC1 is linked to malignant colon neoplasm.